33 studies found for:    " August 22, 2007":" September 21, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" August 22, 2007":" September 21, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (33 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM5)
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Interventions: Drug: Vicriviroc;   Drug: Placebo
2 Terminated HIV - Monotherapy in Switzerland (MOST-ch)
Condition: HIV Infections
Interventions: Drug: Lopinavir-Monotherapy;   Drug: HAART
3 Unknown  A Phase 1 Safety and Immunogenicity Study of the Epitope Based DNA Vaccine (EP HIV-1090) in HIV-1 Infected Individuals Receiving Antiretroviral Therapy (ART)
Condition: HIV Infections
Intervention: Biological: EP1090
4 Completed Feasibility and Pilot Efficacy of Flash-heated Breast Milk to Reduce Maternal-to-Child-Transmission of HIV in Tanzania
Condition: HIV Infections
Intervention: Procedure: Infant feeding counseling that includes Flash-heat
5 Completed A Randomized Controlled Trial of a Mindfulness-Based Stress Reduction Intervention for Men Living With HIV
Condition: HIV Infections
Interventions: Behavioral: MBSR group;   Other: Control
6 Completed Phase I Safety and Immunogenicity Preventative Vaccine Trial Based on Recombinant Tat Protein
Condition: HIV Infections
Intervention: Biological: Biologically active recombinant Tat protein
7 Completed
Has Results
HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and Breastfeeding
Conditions: HIV Infections;   Herpes Simplex
Interventions: Drug: valacyclovir;   Drug: placebo
8 Completed Safety and Effectiveness of PENNVAX-B Vaccine Alone, With Il-12, or IL-15 in Healthy Adults
Condition: HIV Infections
Interventions: Biological: PennVax B;   Biological: IL-12;   Biological: IL-15
9 Unknown  HIV Antiretroviral Drugs and Metabolism
Condition: HIV Infections
Intervention: Drug: ritonavir, lopinavir/ritonavir, atazanavir/ritonavir, efavirenz
10 Completed Integrase Inhibitor (MK-0518) Viral Decay
Condition: HIV Infections
Interventions: Drug: Raltegravir (MK0518);   Drug: Placebo;   Procedure: Leukopheresis;   Procedure: Sigmoid Biopsy
11 Completed Interactions Between HIV and Malaria in African Children
Conditions: Malaria;   HIV Infections
Interventions: Drug: Dihydroartemisinin-piperaquine;   Drug: Artemether-lumefantrine;   Drug: Trimethoprim-sulfamethoxazole
12 Completed Bioequivalency Study of Zidovudine Under Fasting Conditions
Condition: HIV Infections
Intervention: Drug: Zidovudine
13 Completed Double Protease Inhibitor to Darunavir Switch Study
Condition: HIV Infections
Intervention: Drug: Darunavir ritonavir
14 Terminated A Study to Determine the Best Dose of Antivirals in Patients With Both TB and HIV
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: efavirenz or nevirapine
15 Completed Bioequivalency Study of Zidovudine Under Fed Conditions
Condition: HIV Infections
Intervention: Drug: Zidovudine
16 Withdrawn Epoetin Alfa for HIV-Associated Neuropathy Trial
Conditions: HIV Infections;   Neuropathy
Intervention: Drug: epoetin alfa
17 Completed Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvada
Condition: HIV Infections
Interventions: Drug: Atazanavir;   Drug: Ritonavir;   Drug: Tenofovir/emtricitabine
18 Completed Pilot Study of Patients Chronic Hepatitis C in Co-infected HIV Patients Relapsers After Previous Therapies
Conditions: Chronic Hepatitis C;   HIV Infections
Intervention: Drug: Peginterferon alfa-2a plus ribavirin adjusted to body weight
19 Completed Standard Antiretroviral v. Multi-class Therapy in Acutely HIV-1 Infected Antiretroviral-Naïve Subjects (ADARC 2007-01)
Condition: HIV Infections
Interventions: Drug: darunavir;   Drug: Emtricitabine/tenofovir DF;   Drug: Maraviroc;   Drug: Raltegravir
20 Completed Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl
Condition: HIV Infections
Interventions: Drug: tenofovir + emtricitabine + efavirenz;   Drug: tenofovir + emtricitabine + lopinavir-ritonavir;   Drug: tenofovir + emtricitabine + atazanavir-ritonavir

Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results
Indicates status has not been verified in more than two years